Annual Accounts Payable
$9.21 M
-$1.37 M-12.92%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual accounts payable is $9.21 million, with the most recent change of -$1.37 million (-12.92%) on December 31, 2023.
- During the last 3 years, RLAY annual accounts payable has risen by +$2.86 million (+45.03%).
- RLAY annual accounts payable is now -12.92% below its all-time high of $10.58 million, reached on December 31, 2022.
Performance
RLAY Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.87 M
-$4.30 M-38.51%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly accounts payable is $6.87 million, with the most recent change of -$4.30 million (-38.51%) on September 1, 2024.
- Over the past year, RLAY quarterly accounts payable has dropped by -$6.49 million (-48.57%).
- RLAY quarterly accounts payable is now -53.53% below its all-time high of $14.78 million, reached on June 30, 2023.
Performance
RLAY Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RLAY Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.9% | -48.6% |
| 3 y3 years | +45.0% | +8.7% |
| 5 y5 years | +95.8% | - |
RLAY Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.9% | +11.3% | -53.5% | +59.9% |
| 5 y | 5-year | -12.9% | +45.0% | -53.5% | +142.7% |
| alltime | all time | -12.9% | +95.8% | -53.5% | +142.7% |
Relay Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.87 M(-38.5%) |
| Jun 2024 | - | $11.17 M(+40.1%) |
| Mar 2024 | - | $7.97 M(-13.4%) |
| Dec 2023 | $9.21 M(-12.9%) | $9.21 M(-31.0%) |
| Sep 2023 | - | $13.35 M(-9.6%) |
| Jun 2023 | - | $14.78 M(+24.9%) |
| Mar 2023 | - | $11.83 M(+11.9%) |
| Dec 2022 | $10.58 M | $10.58 M(+11.5%) |
| Sep 2022 | - | $9.48 M(+120.8%) |
| Jun 2022 | - | $4.30 M(-46.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $8.05 M(-2.7%) |
| Dec 2021 | $8.28 M(+30.3%) | $8.28 M(+31.0%) |
| Sep 2021 | - | $6.32 M(-19.8%) |
| Jun 2021 | - | $7.87 M(+40.7%) |
| Mar 2021 | - | $5.59 M(-11.9%) |
| Dec 2020 | $6.35 M(-9.2%) | $6.35 M(+39.5%) |
| Sep 2020 | - | $4.55 M(+60.9%) |
| Jun 2020 | - | $2.83 M(-28.5%) |
| Mar 2020 | - | $3.96 M(-43.4%) |
| Dec 2019 | $6.99 M(+48.6%) | $6.99 M |
| Dec 2018 | $4.71 M | - |
FAQ
- What is Relay Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Relay Therapeutics?
- What is Relay Therapeutics annual accounts payable year-on-year change?
- What is Relay Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Relay Therapeutics?
- What is Relay Therapeutics quarterly accounts payable year-on-year change?
What is Relay Therapeutics annual accounts payable?
The current annual accounts payable of RLAY is $9.21 M
What is the all time high annual accounts payable for Relay Therapeutics?
Relay Therapeutics all-time high annual accounts payable is $10.58 M
What is Relay Therapeutics annual accounts payable year-on-year change?
Over the past year, RLAY annual accounts payable has changed by -$1.37 M (-12.92%)
What is Relay Therapeutics quarterly accounts payable?
The current quarterly accounts payable of RLAY is $6.87 M
What is the all time high quarterly accounts payable for Relay Therapeutics?
Relay Therapeutics all-time high quarterly accounts payable is $14.78 M
What is Relay Therapeutics quarterly accounts payable year-on-year change?
Over the past year, RLAY quarterly accounts payable has changed by -$6.49 M (-48.57%)